eConsent for Modern Clinical Trials: How to Deliver Engaging, Compliant and Interactive Remote Consent
Webinar Date/Time: Tuesday, March 21st, 2023 at 9am EDT | 6am PDT | 1pm GMT | 2pm CET
Today, clinical trial sites and sponsors need informed consent solutions that are flexible enough to be delivered in hybrid and decentralized trials. In this webinar, we will discuss how to navigate this complex environment with a flexible, feature-rich eConsent platform can facilitate remote consent from multiple signers in different locations and help sites monitor and track the consent process in real-time throughout the study.
Register Free:
Event Overview:
Today, clinical trial sponsors and sites need informed consent solutions that are flexible enough to meet the demands of hybrid and decentralized models while ensuring patient-centricity and regulatory compliance. That’s why a feature-rich, compliant electronic consent (eConsent) platform that can facilitate a simplified traceable remote consent in diverse locations is critical to delivering modern clinical trials worldwide.
In this webinar, IQVIA Complete Consent leaders will share how eConsent can deliver an engaging informed consent experience while supporting diverse study protocols. We will discuss how to collect remote consent from multiple signers in different locations, while effortlessly monitoring and tracking the process throughout the trial lifecycle.
Three key take-aways:
- Support simple and complex study designs in hybrid consent models
- Collect remote consent from multiple signers in different physical locations
- Monitor and track remote consent progress in real-time
Speakers:
David Lake
Director of Operational Effectiveness, Patient Consent
IQVIA Technologies
David Lake is an operations leader focused on the deployment, training, and implementation of eConsent. With over 16 years of technology, software-as-service (SaaS), and operations experience, David has spent the last six years developing and delivering electronic informed consent platforms – supporting everything from content creation, product development, project management, and process improvement. He is extremely passionate about the benefits of electronic consent, especially the transparency and patient centricity it provides. He is a subject matter expert for IQVIA Complete Consent and enjoys helping customers get the most value out of eConsent for their trials and the patients they serve.
Dana Wershiner
Associate Director of Product, Patient Consent
IQVIA Technologies
With over 25 years of technology expertise, Dana Wershiner is passionate about designing and developing products that truly meets users’ needs while delivering innovation and strategic value. In her current role, Dana leads the IQVIA Complete Consent product team in scoping and documenting new product features, collaborating with engineers, delivery integration, and project management teams to deliver a feature-rich consent solution to customers.
Register Free:
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Operational Strategies That Strengthened the NIMBLE Trial Design
September 16th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- How ClinOps Teams Should Evaluate GenAI Tools in Trial Discovery
September 11th 2025
- Ensuring Digital Trial Platforms Work for Underserved Communities
September 10th 2025
- eClinical Technology: Misconceptions, Challenges, and Opportunities
September 9th 2025
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025